Name:MART-1 (26-35)) (human);
Sequence(Three Letter):H-Glu-Ala-Ala-Gly-Ile-Gly-Ile-Leu-Thr-Val-OH (trifluoroacetate salt);
Sequence(One Letter):EAAGIGILTV;
Cas:[156251-01-3];
Formula:C42H74N10O14;
M.W.:943.11;
Size:1mg,5mg,10mg,50mg,100mg,1g;
Purity:80%,90%,95%,98%,99%;
Storage Temp:Store at -20°C. Keep tightly closed. Store in a cool dry place.;
Reference:A.van Elsas et al., Eur. J. Immunol., 26, 1683 (1996)P.Romero et al., J. Immunol., 159, 2366 (1997)D.Valmori et al., J. Immunol., 160, 1750 (1998)Q.Chen et al., Cancer Immunol. Immunother., 47, 191 (1998)K.S.Lang et al., J. Invest. Dermatol., 116, 891 (2001);
Description:MART-1 (26-35) has been shown to be better recognized by a number of polyclonal and monoclonal populations of tumor-reactive HLA-A*0201-restricted cytotoxic T lymphocytes (CTL) than MART-1 (27-35) (human)